A Novo Nordisk experimental drug failed to reduce the risk of heart attacks and strokes in a large study, a blow to the drugmaker’s growth prospects beyond obesity and diabetes https://t.co/MFrUJa4F3r ...

Millions of people are now taking GLP-1 medications such as Zepbound, Wegovy and Ozempic. So taking a trip requires extra planning and preparation.Here are expert-backed tips to ensure a good trip: https://t.co/X2V9o92kXIPhoto: Indranil Mukherjee/AFP via Getty Images https://t.co/EPdEjp4vkm ...

India’s second-largest money manager is bullish on banks, oil refiners, power utilities and drugmakers, betting they are best placed to benefit from demand tailwinds despite a volatile global backdrop https://t.co/nHhVys7E55 ...

Independent experts voted 10-3 despite regulators’ concern about the design of the company’s pivotal cancer trial. https://t.co/l5iT3dRdMG ...

The weight-loss drug boom is beginning to show signs of a slowdown as employers and insurers pull back on coverage, signaling the market could be entering a more restrained phase after years of breakneck expansion https://t.co/qx74Utphq0 ...

Bristol Myers boosted its sales and profit outlook for 2026 after second-quarter demand for most of the drugmaker’s portfolio beat Wall Street’s expectations, led by newer medicines for heart conditions and cancer. https://t.co/R9azm5DP8J ...